Axon-glial disruption: The link between vascular disease and Alzheimer's disease?

Biochemical Society Transactions

Volumn 39, Issue 4, 2011, Pages 881-885

  Horsburgh, Karen ^a   Reimer, Michell M ^a   Holland, Philip ^a   Chen, Guiquan ^a   Scullion, Gillian ^a   Fowler, Jill H ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

peptide (A ); Alzheimer's disease (AD); Amyloid ; Axon glial integrity; Hypoperfusion; Vascular disease; White matter

Indexed keywords

AMYLOID; AMYLOID BETA 42 SPECIFIC INTRACELLULAR ANTIBODY; AMYLOID BETA PROTEIN; ANTIBODY; GLUTAMIC ACID; MYELIN; PRESENILIN 1; UNCLASSIFIED DRUG;

AGING; ALZHEIMER DISEASE; AUTOREGULATION; BLOOD VESSEL REACTIVITY; BRAIN BLOOD FLOW; BRAIN INJURY; BRAIN ISCHEMIA; CELL ACTIVATION; CELL DISRUPTION; COGNITIVE DEFECT; CONFERENCE PAPER; DIFFUSION TENSOR IMAGING; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ELECTRON MICROSCOPY; GENE MUTATION; GLIA; GRAY MATTER; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; MYELINATION; NERVE CELL DEGENERATION; NERVE FIBER; NEUROTOXICITY; NONHUMAN; NONMYELINATED NERVE; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIA; PERFUSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULAR DISEASE; VASCULARIZATION; WHITE MATTER; WORKING MEMORY;

ALZHEIMER DISEASE; ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, TRANSGENIC; PLAQUE, AMYLOID; VASCULAR DISEASES;

EID: 79960873703     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0390881     Document Type: Conference Paper

References (45)

1. Nave, K.A. (2010) Myelination and support of axonal integrity by glia. Nature 468, 244-252
2. Bastin, M.E., Clayden, J.D., Pattie, A., Gerrish, I.F., Wardlaw, J.M. and Deary, I.J. (2009) Diffusion tensor and magnetization transfer MRI measurements of periventricular white matter hyperintensities in old age. Neurobiol. Aging 30, 125-136
3. Bucur, B., Madden, D.J., Spaniol, J., Provenzale, J.M., Cabeza, R., White, L.E. and Huettel, S.A. (2008) Age-related slowing of memory retrieval: contributions of perceptual speed and cerebral white matter integrity. Neurobiol. Aging 29, 1070-1079 (Pubitemid 351697991)
4. Deary, I.J., Leaper, S.A., Murray, A.D., Staff, R.T. and Whalley, L.J. (2003) Cerebral white matter abnormalities and lifetime cognitive change: a 67-year follow-up of the Scottish Mental Survey of 1932. Psychol. Aging 18, 140-148 (Pubitemid 36293051)
5. Penke, L., Muñoz Maniega, S., Murray, C., Gow, A.J., Hernández, M.C., Clayden, J.D., Starr, J.M., Wardlaw, J.M., Bastin, M.E. and Deary, I.J. (2010) A general factor of brain white matter integrity predicts information processing speed in healthy older people. J. Neurosci. 30, 7569-7574
6. Bartzokis, G. (2004) Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease. Neurobiol. Aging 25, 5-18
7. Brun, A. and Englund, E. (1986) Brain changes in dementia of Alzheimer's type relevant to new imaging diagnostic methods. Prog. Neuropsychopharmacol. Biol. Psychiatry 10, 297-308
8. Song, S.K., Kim, J.H., Lin, S.J., Brendza, R.P. and Holtzman, D.M. (2004) Diffusion tensor imaging detects age-dependent white matter changes in a transgenic mouse model with amyloid deposition. Neurobiol. Dis. 15, 640-647
9. Sun, S.W., Song, S.K., Harms, M.P., Lin, S.J., Holtzman, D.M., Merchant, K.M. and Kotyk, J.J. (2005) Detection of age-dependent brain injury in a mouse model of brain amyloidosis associated with Alzheimer's disease using magnetic resonance diffusion tensor imaging. Exp. Neurol. 191, 77-85
10. Brun, A. and Englund, E.A. (1986) A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann. Neurol. 19, 253-262
11. Roher, A.E., Weiss, N., Kokjohn, T.A., Roher, A.E., Weiss, N., Kokjohn, T.A., Kuo, Y.M., Kalback, W., Anthony, J., Watson, D. et al. (2002) Increased Aβ peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer's disease. Biochemistry 41, 11080-22090
12. Peters, A., Moss, M.B. and Sethares, C. (2000) Effects of aging on myelinated nerve fibers in monkey primary visual cortex. J. Comp. Neurol. 419, 364-376
13. Umahara, T., Tsuchiya, K., Ikeda, K., Kanaya, K., Iwamoto, T. and Takasaki, M. (2002) Demonstration and distribution of tau-positive glial coiled body-like structures in white matter and white matter threads in early onset Alzheimer's disease. Neuropathology 22, 9-12 (Pubitemid 34538681)
14. Stokin, G.B., Lillo, C. and Falzone, T.L. (2005) Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 307, 1282-1288 (Pubitemid 40299973)
15. Desai, M.K., Sudol, K.L., Janelsins, M.C., Mastrangelo, M.A., Frazer, M.E. and Bowers, W.J. (2009) Triple-transgenic Alzheimer's disease mice exhibit region-specific abnormalities in brain myelination patterns prior to appearance of amyloid and tau pathology. Glia 57, 54-65
16. Hu, X., Hicks, C.W., He, W., Wong, P., Macklin, W.B., Trapp, B.D. and Yan, R. (2006) BACE1 modulates myelination in the central and peripheral nervous system. Nat. Neurosci. 9, 1520-1525
17. Huth, T., Schmidt-Neuenfeldt, K., Rittger, A., Saftig, P., Reiss, K. and Alzheimer, C. (2009) Non-proteolytic effect of β-site APP-cleaving enzyme 1 (BACE1) on sodium channel function. Neurobiol. Dis. 33, 282-289
18. Kim, D.Y., Carey, B.W., Wang, H., Ingano, L.A., Binshtok, A.M., Wertz, M.H., Pettingell, W.H., He, P., Lee, V.M., Woolf, C.J. and Kovacs, D.M. (2007) BACE1 regulates voltage-gated sodium channels and neuronal activity. Nat. Cell Biol. 9, 755-764
19. Wong, H.K., Sakurai, T., Oyama, F., Kaneko, K., Wada, K., Miyazaki, H., Kurosawa, M., De Strooper, B., Saftig, P. and Nukina, N. (2005) β-Subunits of voltage-gated sodium channels are novel substrates of β-site amyloid precursor protein-cleaving enzyme (BACE1) and γ-secretase. J. Biol. Chem. 280, 23009-23017 (Pubitemid 40853211)
20. Fernando, M.S., Simpson, J.E., Matthews, F., Brayne, C., Lewis, C.E., Barber, R., Kalaria, R.N., Forster, G., Esteves, F., Wharton, S.B. et al. (2006) White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury. Stroke 37, 1391-1398 (Pubitemid 44305715)
21. Farkas, E. and Luiten, P.G. (2001) Cerebral microvascular pathology in aging and Alzheimer's disease. Prog. Neurobiol. 64, 575-611
22. Love, S. (2004) Contribution of cerebral amyloid angiopathy to Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 75, 1-4
23. Ruitenerg, A., den Heijer, T., Bakker, S.L., van Swieten, J.C., Koudstaal, P.J., Hofman, A. and Breteler, M.M. (2005) Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam study. Ann. Neurol. 57, 789-794
24. Farkas, E., Luiten, P.G. and Bari, F. (2007) Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases. Brain Res. Rev. 54, 162-180
25. Kalaria, R.N. (1996) Cerebral vessels in ageing and Alzheimer's disease. Pharmacol. Ther. 72, 193-214
26. Shibata, M., Ohtani, R., Ihara, M. and Tomimoto, H. (2004) White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion. Stroke. 35, 2598-2603 (Pubitemid 39458424)
27. Coltman, R., Spain, A., Tsenkina, Y., Fowler, J.H., Smith, J., Scullion, G., Allerhand, M., Scott, F., Kalaria, R.N., Ihara, M. et al. (2010) Selective white matter pathology induces a specific impairment in spatial working memory. Neurobiol. Aging, doi:10.1016/j.neurobiolaging.2010.09.005
28. Holland, P.R., Bastin, M.E., Jansen, M.A., Merrifield, G.D., Coltman, R.B., Scott, F., Nowers, H., Khallout, K., Marshall, I., Wardlaw, J. et al. (2010) MRI is a sensitive marker of subtle white matter pathology in hypoperfused mice. Neurobiol. Aging, doi:10.1016/j.neurobiolaging.2010.11.009
29. Bayer, T.A. and Wirths, O. (2010) Intracellular accumulation of amyloid-β: a predictor for synaptic dysfunction and neuron loss in Alzheimer's disease. Front. Aging Neurosci. 10, 2-8
30. Skaper, S.D., Evans, N.A., Soden, P.E., Rosin, C., Facci, L. and Richardson, J.C. (2009) Oligodendrocytes are a novel source of amyloid peptide generation. Neurochem. Res. 34, 2243-2250
31. Geula, C., Wu, C.K., Saroff, D., Lorenzo, A., Yuan, M. and Yankner, B.A. (1998) Aging renders the brain more vulnerable to amyloid β-protein neurotoxicity. Nat. Med. 4, 827-831 (Pubitemid 28331025)
32. Xu, J., Chen, S., Ahmed, S.H., Chen, H., Ku, G., Goldberg, M.P. and Hsu, C.Y. (2001) Amyloid-β peptides are cytotoxic to oligodendrocytes. J. Neurosci. 118, 1-5
33. Desai, M.K., Mastrangelo, M.A., Ryan, D.A., Sudol, K.L., Narrow, W.C. and Bowers, W.J. (2010) Early oligodendrocyte/myelin pathology in Alzheimer's disease mice constitutes a novel therapeutic target. Am. J. Pathol. 177, 1422-1435
34. Pak, K., Chan, S.L. and Mattson, M.P. (2003) Presenilin-1 mutation sensitizes oligodendrocytes to glutamate and amyloid toxicities, and exacerbates white matter damage and memory impairment in mice. Neuromol. Med. 3, 53-64
35. Liao, M.C., Ahmed, M., Smith, S.O. and Van Nostrand, W.E. (2009) Degradation of amyloid β protein by purified myelin basic protein. J. Biol. Chem. 284, 28917-28925
36. Horsburgh, K. and Nicoll, J.A.R. (1996) Selective cellular alterations in amyloid precursor protein and apolipoprotein E following transient cerebral ischaemia in the rat. Alzheimer's Res. 2, 37-42 (Pubitemid 26199099)
37. Horsburgh, K., Mackay, K. and McCulloch, J. (1997) Intracortical glutamate perfusion in vivo induces specific alterations in protein kinase C isoforms and amyloid precursor protein. Exp. Neurol. 143, 207-218
38. Kalaria, R.N., Bhatti, S.U., Lust, W.D. and Perry, G. (1993) The amyloid precursor protein in ischemic brain injury and chronic hypoperfusion. Ann. N.Y. Acad. Sci. 695, 190-193
39. van Groen, T., Puurunen, K., Mäki, H.-M., Sivenius, J. and Jolkkonen, J. (2005) Transformation of diffuse β-amyloid precursor protein and β-amyloid deposits to plaques in the thalamus after transient occlusion of the middle cerebral artery in rats. Stroke 36, 1551-1556
40. Kitaguchi, H., Tomimoto, H., Ihara, M., Shibata, M., Uemura, K., Kalaria, R.N., Kihara, T., Asada-Utsugi, M., Kinoshita, A. and Takahashi, R. (2009) Chronic cerebral hypoperfusion accelerates amyloid β deposition in APPSwInd transgenic mice. Brain Res. 1294, 202-210
41. Koike, M.A., Green, K.N., Blurton-Jones, M. and Laferla, F.M. (2010) Oligemic hypoperfusion differentially affects tau and amyloid-β. Am. J. Pathol. 177, 300-310
42. Thomas, T., Thomas, G., McLendon, C., Sutton, T. and Mullan, M. (1996) β-Amyloid-mediated vasoactivity and vascular endothelial damage. Nature 380, 168-171
43. Niwa, K., Kazama, K., Younkin, S.G., Carlson, G.A. and Iadecola, C. (2002) Alterations in cerebral blood flow and glucose utilization in mice overexpressing the amyloid precursor protein. Neurobiol. Dis. 9, 61-68
44. Niwa, K., Kazama, K., Younkin, L., Younkin, S.G., Carlson, G.A. and Iadecola, C. (2002) Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein. Am. J. Physiol. Heart Circ. Physiol. 283, H315-H323
45. Zhang, F., Eckman, C., Youkin, S., Hsiao, K.K. and Iadecola, C. (1997) Increased susceptibility to ischemic brain damage in transgenic mice overexpressing amyloid precursor protein. J. Neurosci. 17, 7655-7661 (Pubitemid 27426204)